Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameFLOSEAL MATRIX (AKA PROCEED) HEMOSTATIC SEALANT
Classification Nameagent, absorbable hemostatic, collagen based
Generic Namegelatin matrix hemostatic sealant
Regulation Number878.4490
ApplicantFUSION MEDICAL TECHNOLOGIES, INC.
PMA NumberP990009
Supplement NumberS004
Date Received01/16/2001
Decision Date02/28/2001
Product Code
LMF[ Registered Establishments with LMF ]
Advisory Committee General & Plastic Surgery
Supplement Typereal-time process
Supplement Reason change design/components/specifications - specifications
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for an increase in an intermediate specification for residual glutaraldehyde from 20 to 40 ppm.
-
-